| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/20/2002 | US6436443 Porous particles comprising excipients for deep lung delivery |
| 08/20/2002 | US6436442 Process of manufacturing compositions comprising cyclodextrin |
| 08/20/2002 | US6436441 Hydrogel-forming sustained-release preparation |
| 08/20/2002 | US6436440 Use of N-vinyllactam-or-N-vinylamine-containing copolymers as matrix for producing solid pharmaceutical and cosmetic presentations |
| 08/20/2002 | US6436439 Agricultural chemicals |
| 08/20/2002 | US6436438 Tramadol multiple unit formulations |
| 08/20/2002 | US6436436 Aqueous carrier systems for water-insoluble aromatic polymers |
| 08/20/2002 | US6436435 Liposome formulation of 5 β steroids |
| 08/20/2002 | US6436433 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties |
| 08/20/2002 | US6436430 Self-emulsifying compositions for drugs poorly soluble in water |
| 08/20/2002 | US6436429 Process and composition for temporarily suppressing pain |
| 08/20/2002 | US6436428 Device and method for treating urinary incontinence in females |
| 08/20/2002 | US6436427 Device and method for treating ophthalmic diseases |
| 08/20/2002 | US6436425 Administering aqueous formulation comprising polyoxyalkylene block cpolymer and water to tissues of mammal for inhibiting the formation/reformation of internal adhesions |
| 08/20/2002 | US6436385 Trimethylglycine compound |
| 08/20/2002 | US6436369 Anti-plaque emulsions and products containing same |
| 08/20/2002 | US6436368 Process for preparing beclomethasone dipropionate freon® clathrate |
| 08/20/2002 | US6436367 Aerosol formulations for buccal and pulmonary application |
| 08/20/2002 | US6436091 Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| 08/20/2002 | US6436069 Substance delivery device |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | CA2271895C Substituted amylose as a matrix for sustained drug release |
| 08/20/2002 | CA2255663C Antifungal composition with enhanced bioavailability |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2202676C Biodegradable polyanhydrides derived from dimers of bile acids, and use thereof as controlled drug release systems |
| 08/20/2002 | CA2197496C Composition including a dispersion of polymeric particles in a non-aqueous medium |
| 08/20/2002 | CA2182577C Lipophilic carrier preparations |
| 08/20/2002 | CA2164321C Plasma-like solution |
| 08/20/2002 | CA2150372C Stable oral ci-981 formulation and process of preparing same |
| 08/20/2002 | CA2111697C A process for producing suppositories by compression and suppositories obtained by the process |
| 08/20/2002 | CA2106573C Debridement of bodily cavities using debridement fluids |
| 08/20/2002 | CA2072366C carboxylic acid-metal ion-acid complexes |
| 08/15/2002 | WO2002063260A2 Skin patch including a temperature sensor |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | WO2002062833A2 Modified leptin with reduced immunogenicity |
| 08/15/2002 | WO2002062832A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | WO2002062782A1 Method for the production of dronabinol |
| 08/15/2002 | WO2002062422A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
| 08/15/2002 | WO2002062416A1 Apparatus for dispensing powdered material |
| 08/15/2002 | WO2002062415A1 Geometry retainable devices for body cavities |
| 08/15/2002 | WO2002062404A2 Closure of ruptured tissue and bulking of tissue |
| 08/15/2002 | WO2002062394A2 Vegetable polymer-based composition that immobilises active agents |
| 08/15/2002 | WO2002062393A2 Coating for orally administered compositions |
| 08/15/2002 | WO2002062392A2 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | WO2002062375A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | WO2002062368A2 Method of inducing a ctl response |
| 08/15/2002 | WO2002062352A2 Devices and methods for management of bone density |
| 08/15/2002 | WO2002062350A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | WO2002062344A1 Method of administering ophthalmic fluids |
| 08/15/2002 | WO2002062340A1 Highly lipophilic camptothecin prodrugs, methods of preparation, and formulations thereof |
| 08/15/2002 | WO2002062338A1 Parenteral formulation containing epothilone analogs |
| 08/15/2002 | WO2002062336A1 Antifungal remedy formulation for external application |
| 08/15/2002 | WO2002062335A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 08/15/2002 | WO2002062331A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/15/2002 | WO2002062321A2 Method for producing a floating tablet containing an active principle |
| 08/15/2002 | WO2002062320A1 Methods and compositions for reducing the taste of pharmaceutically active agents |
| 08/15/2002 | WO2002062319A2 Microsphere delivery of mucin peptides |
| 08/15/2002 | WO2002062318A2 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | WO2002062317A2 Bimodal dry powder formulation for inhalation |
| 08/15/2002 | WO2002062316A1 Invasomes for the treatment of disease states, production and use thereof |
| 08/15/2002 | WO2002062315A1 Rapid-onset medicament for the treatment of sexual dysfunction |
| 08/15/2002 | WO2002062314A1 Oral drug delivery system |
| 08/15/2002 | WO2002062310A1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 08/15/2002 | WO2002062299A2 Improved controlled release oral dosage form |
| 08/15/2002 | WO2002062276A1 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use |
| 08/15/2002 | WO2002062260A2 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/15/2002 | WO2002062152A1 Water soluble powders and tablets |
| 08/15/2002 | WO2002051800A3 Sulphur-containing amphiphilic agents for the transfer of biologically active molecules into cells |
| 08/15/2002 | WO2002048199A3 Production of carrageenan and carrageenan products |
| 08/15/2002 | WO2002047685A3 Nmda receptor agonist pharmaceutical compositions |
| 08/15/2002 | WO2002019989A3 Alginate particle formulation |
| 08/15/2002 | WO2002019961A3 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 08/15/2002 | WO2002015965A3 Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
| 08/15/2002 | WO2002015938A3 Testosterone ester formulation for human use |
| 08/15/2002 | WO2002013793A3 Method of making tablets and tablet compositions produced therefrom |
| 08/15/2002 | WO2002013783A3 Process for preparing polymer-based sustained release compositions |
| 08/15/2002 | WO2002007707A3 Linkage of agents using microparticles |
| 08/15/2002 | WO2002005870A3 Kits and compositions supporting intracranial perfusions |
| 08/15/2002 | WO2002003848A3 Method for opening the blood-brain barrier |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2001091726A9 Acne-treating composition |
| 08/15/2002 | WO2001087270B1 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 08/15/2002 | WO2001049246A3 Sustained release tablet formulations comprising clarithromycin |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034192A9 Improved method of immunization |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | US20020111603 Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process |
| 08/15/2002 | US20020111392 Biodegradation; insertion into body, crosslinking |
| 08/15/2002 | US20020111387 Pharmaceutical dosage form for transdermal administration |
| 08/15/2002 | US20020111386 Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
| 08/15/2002 | US20020111383 Ultrafine L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 08/15/2002 | US20020111381 Vision disorders; topical applying |
| 08/15/2002 | US20020111377 Transdermal delivery of cannabinoids |
| 08/15/2002 | US20020111366 Therapy for brain disorders; strokes |
| 08/15/2002 | US20020111363 Antihistamines; atomizing |
| 08/15/2002 | US20020111360 Quinazoline formulations and therapeutic use thereof |
| 08/15/2002 | US20020111359 Side effect reduction of narcotics |